United Therapeutics Chairperson, CEO Martine Rothblatt disposes of shares worth $4.91 million

Bitget2026/10/06 20:32

United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 117.76 on Oct. 5, 2026. Family trust sold 8,500 shares the same day at weighted-average prices ranging from USD 536.2579 to USD 546.6322. Trust holdings fell to 324,443 shares following the sales. Trust-held stock options rose to 299,910 following the exercise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000157), on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

SWIFT, Ripple (XRP) & BNP Paribas: Connecting The Dots

DailyCoin•2026/10/17 13:48

Did Satoshi Get Bitcoin Wrong? Claude's NSA Discovery Sparks Debate

BeInCrypto•2026/10/17 13:09

2 Banking Giants Make Major Crypto Moves as Schwab and Deutsche Bank Expand Into Digital Assets

Cryptopotato•2026/10/17 11:27

Circle’s Allaire says stablecoin issuer looking to enter 40 developing markets: Report

Cointelegraph•2026/10/17 10:09